Nitazene Sanctions Act
Sponsored By: Senator Sen. Ricketts, Pete [R-NE]
Introduced
Summary
Expands U.S. sanctions to target nitazene synthetic opioids and PRC-linked producers and officials. It amends the Fentanyl Sanctions Act to add 2‑benzylbenzimidazole opioids (nitazenes), broaden ‘‘controlled substances’’ language, and extend the law’s authorization from 5 to 10 years.
Show full summary
- PRC entities and officials face new exposure. The President can designate Chinese companies and senior officials as foreign opioid traffickers if they produce, finance, transport, or fail to take credible steps like know‑your‑customer checks to stop nitazene precursors.
- U.S. diplomacy and law enforcement must report fast. The Secretary of State and Attorney General must jointly deliver an unclassified report within 120 days describing PRC roles in precursor production, a plan to work with the PRC to reduce production, and a strategy to coordinate with European allies.
- Foreign governments and state‑linked institutions can be sanctioned. The President may impose penalties on foreign agencies, subdivisions, or government‑owned financial institutions that knowingly support precursor development or transport for synthetic opioids.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Add nitazenes to covered drugs
This bill would add nitazenes (called 2‑benzylbenzimidazole opioids) to the Fentanyl Sanctions Act's list of synthetic opioids. If enacted, that would let the government use the Act's sanctions and tools against nitazene production and precursor chains. The change would take effect when the bill is enacted.
China entities and officials targeted
This bill would let the President designate certain People's Republic of China entities as foreign opioid traffickers. It covers PRC companies that produce, sell, finance, or move listed opioid precursors and that fail to take credible anti-trafficking steps. It would also allow naming senior PRC officials who oversee those entities and even consider the heads of four named China agencies when deciding designations. These changes would take effect if the bill is enacted.
Stronger sanctions on foreign governments
This bill would let the President sanction parts of a foreign government. That can include state-owned banks and agencies that knowingly help opioid trafficking or precursor transport. It would apply when those entities knowingly supported precursor development, transport, or other significant trafficking activity on or after enactment. The bill would also extend the Fentanyl Sanctions Act authorization window from 5 years to 10 years. These changes would take effect if the bill is enacted.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Sen. Ricketts, Pete [R-NE]
NE • R
Cosponsors
Eric Schmitt
MO • R
Sponsored 10/30/2025
Sen. McCormick, David [R-PA]
PA • R
Sponsored 10/30/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in